De Prisco M, Tapoi C, Oliva V, Strumila R, Takami C, Girone N, Macellaro M, de Salles Andrade JB, Schmitz C, Vieta E, Fico G. Clinical impact of obsessive-compulsive disorder comorbidity in bipolar disorder: a systematic review and meta-analysis. Eur Psychiatry. 2025 Aug 26. [Epub ahead of print] :1-34.
Gründer G, Mertens L, Spangemacher M, Schmitz C. [Can antidepressants negatively alter the long-term course of depressive disorders?]. Nervenarzt. 2025 96(2):146-152. Epub 2025 Feb 24.
Schmitz C, Sammer G, Neumann E, Blecker C, Gründer G, Adolphi H, Lamadé EK, Pedraz-Petrozzi B. Functional resting state connectivity is differentially associated with IL-6 and TNF-α in depression and in healthy controls. Sci Rep. 2025 15(1):1769.
Schmitz CN, Hart XM, Spangemacher M, Roth JL, Lazarevic I, Oberthür G, Büsing KA, Becker R, Cumming P, Gründer G. Neurovascular coupling of striatal dopamine D receptor availability and perfusion using simultaneous PET/MR in humans. Neurosci Appl. 2025 3:104094.
Spangemacher M, Reinwald J, Adolphi H, Kärtner L, Mertens LJ, Schmitz CN, Gründer G. [Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment]. Nervenarzt. 2025 96(2):119-127. Epub 2025 Jan 16.
Spangemacher M, Schmitz C, Cumming P, Färber LV, Hart XM, Uchida H, Gründer G. The sense and nonsense of antipsychotic combinations: A model for dopamine D receptor occupancy. Transl Psychiatry. 2025 15(1):348.